Inicio>>Peptides>>Retatrutide (sodium salt)

Retatrutide (sodium salt) (Synonyms: LY3437943)

Catalog No.GC91869

Retatrutide is a triple agonist of the glucagon receptor (GCGR), glucagon-like peptide 1 receptor (GLP-1R), and gastric inhibitory polypeptide receptor (GIP receptor), also known as the glucose-dependent insulinotropic polypeptide receptor.

Products are for research use only. Not for human use. We do not sell to patients.

Retatrutide (sodium salt) Chemical Structure

Cas No.: N/A

Tamaño Precio Disponibilidad Cantidad
1 mg
80,00 $
Disponible
5 mg
379,00 $
Disponible
10 mg
718,00 $
Disponible
25 mg
1.397,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Retatrutide is a triple agonist of the glucagon receptor (GCGR), glucagon-like peptide 1 receptor (GLP-1R), and gastric inhibitory polypeptide receptor (GIP receptor), also known as the glucose-dependent insulinotropic polypeptide receptor.[1] It induces cAMP accumulation in HEK293 cells expressing the human GCGR, GLP-1R, or GIP receptor (EC50s = 5.79, 0.775, and 0.0643 nM, respectively). Retatrutide (0.1-30 nmol/kg) decreases plasma glucose levels in an intraperitoneal glucose tolerance test in mice. It decreases body weight, calorie intake, fat mass, and lean mass in a mouse model of diet-induced obesity in a dose-dependent manner. Acute administration of retatrutide (10 nmol/kg) delays gastric emptying and chronic administration for 10 days decreases food intake and body weight in mice.[2]

References:
[1].Coskun, T., Urva, S., Roell, W.C., et al.LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of conceptCell Metab.34(9)1234-1247(2022).
[2].Urva, S., O'Farrell, L., Du, Y., et al.The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptyingDiabetes Obes. Metab.25(9)2784-2788(2023).

Reseñas

Review for Retatrutide (sodium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Retatrutide (sodium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.